Screener
Medpace Holdings, Inc. MEDP Direct Costs — Segment Reporting, Other Segment Item, Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001668397-26-000025
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue, net | $707,331 | $603,311 | $1,413,935 | $1,161,881 |
| Operating expenses: | ||||
| Direct service costs, excluding depreciation and amortization - Employee compensation | 163,089 | 147,942 | 327,692 | 291,869 |
| Direct service costs, excluding depreciation and amortization - Other segment items (a) | 39,466 | 37,884 | 73,137 | 71,773 |
| Reimbursed out-of-pocket expenses | 303,139 | 237,472 | 615,143 | 439,876 |
| Total direct costs | 505,694 | 423,298 | 1,015,972 | 803,518 |
| Selling, general and administrative | 48,103 | 46,664 | 96,020 | 104,561 |
| Depreciation | 6,555 | 6,777 | 13,306 | 13,471 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount?
- Medpace Holdings, Inc. (MEDP) reported direct costs — segment reporting, other segment item, amount of $39.47M in Q2 2026.
- How has Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount changed year-over-year?
- Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount increased by 4.2% year-over-year, from $37.88M to $39.47M.
- What is the long-term trend for Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount?
- Over 3 years (2022 to 2025), Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount has grown at a 4.8% compound annual growth rate (CAGR), from $124.38M to $143.34M.
- What does direct costs — segment reporting, other segment item, amount mean?
- This metric represents ancillary or non-labor direct costs associated with the delivery of clinical trial services, such as specialized equipment, third-party vendor fees, or facility-related expenses. It isolates the non-personnel direct expenditures that are necessary to support the broader clinical research infrastructure. Analyzing this helps identify trends in overhead-related direct costs that are distinct from core payroll expenses.
Ask your AI about Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude